[A synthetic pyrimidinyl sulfonamide derivative, short-acting bacteriostatic Sulfadiazine inhibits bacterial folic acid synthesis by competing with para amino benzoic acid. It is used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. (NCI04) ( NCI )]
UMLS (NCI) C0038675 - Organic Chemical
- Pharmacologic Substance
Relation/PAR: Sulfanilamides
[AM650] SULFONAMIDE/RELATED ANTIMICROBIALS
Relation/CHD: Silver Sulfadiazine
SULFADIAZINE 500 MG
SULFADIAZINE 167 MG
SULFADIAZINE 167 MG/5ML